TrialNature communications2019
A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.
Ryota Tamura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this papertrialcites it
TrialNature communications2019
Ryota Tamura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.